Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1900 (-2.83%) ($6.1200 - $6.4500) on Tue. Oct. 4, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.1% (three month average) | RSI | 21 | Latest Price | $6.1900(-2.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) EWG(4%) TBT(4%) URA(4%) XRT(3%) DIA(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.05% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) BWX(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.05% (StdDev 2.1%) | Hourly BBV | 0 () | Intraday Trend | -3.1% | | | |
|
1 - 5 Day Possible Target | $-1.65(-126.66%) | Resistance Level | $6.68 | 5 Day Moving Average | $6.33(-2.21%) | 10 Day Moving Average | $6.5(-4.77%) | 20 Day Moving Average | $6.68(-7.34%) | To recent high | -16.5% | To recent low | 0% | Market Cap | $512m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |